SCHEMBL26089329

SCHEMBL26089329

CCC1c2c(O)c(C(=O)O)c(=O)n(C)c2CCC1(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26088430 0.72 HNF4A (0.35) —
SCHEMBL26087011 0.72 AHR (0.34) —
SCHEMBL26088305 0.72 AHR (0.34) —
SCHEMBL26088868 0.72 AHR (0.34) —
SCHEMBL26086567 0.64 LMNA (0.44) —
SCHEMBL31514430 0.64 TSHR (0.45) —
SCHEMBL26086552 0.61 AHR (0.38) —
SCHEMBL26088630 0.61 ALDH1A1 (0.47) —
SCHEMBL26419161 0.61 ALDH1A1 (0.47) —
SCHEMBL26089326 0.60 ALDH1A1 (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127797-A1 AHR AGONISTS ELI LILLY AND COMPANY 2023-04-27 — — US disclosed
Send feedback